Skip to content

EV / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Staar Surgical logo
Staar SurgicalSTAA
4.2×+1.5×
Bausch + Lomb logo
Bausch + LombBLCO
0.0×
RxSight, Inc. logo
RxSight, Inc.RXST
1.9×-4.8×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
7.3×-2.6×
IAR
Integra LifeSciencesIART
1.5×-0.6×

Other financials

Income statement

See full
Revenue$13.4M-5.2%
Gross profit$6.4M-10.4%
Operating income$2.2M+139%
Net income$36.3M+233%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$12.5M-36.1%
Total debt$7.6M+206%
Total equity$10.8M+149%
Total assets$66.2M-9.2%

Cash flow

See full
Operating cash flow-$4.3M+38.4%
CapEx$77.0K-31.9%
Free cash flow-

Valuation

See full
Market cap$70.13M-47.4%
Enterprise value$65.21M-49.0%
P/E2.4×
P/S1.2×-1.1×

Profitability

See full
Gross margin45.7%-2.1pp
Operating margin-28.7%+7.3pp
Net margin50.9%+30.7pp
FCF margin-26.6%

Returns & leverage

See full
Return on equity-164%-235pp
Debt / equity0.7×
Current ratio2.4×+0.6×

Where this comes from

Calculated from LENSAR, Inc.’s reported figures.

Based on the most recent quarter.

The official record: LENSAR, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about LENSAR, Inc.'s ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LENSAR, Inc.'s EV / sales?
LENSAR, Inc. (LNSR) reported EV / sales of 1.2× in Q1 2026.
How has LENSAR, Inc.'s EV / sales changed year-over-year?
LENSAR, Inc.'s EV / sales decreased by 55.9% year-over-year, from 2.6× to 1.2×.
What is the long-term trend for LENSAR, Inc.'s EV / sales?
Over 5 years (2020 to 2025), LENSAR, Inc.'s EV / sales has grown at a 14.3% compound annual growth rate (CAGR), from 1.1× to 2.2×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.